Literature DB >> 20730574

Depression after myocardial infarction.

Melvin R Echols1, Christopher M O'Connor.   

Abstract

Depression is an important disease state that requires significant time and resources to manage properly. The presence of depression in patients with cardiovascular disease has been strongly associated with detrimental effects in terms of morbidity and mortality. Although several large-scale and small studies have evaluated various interventions in the management of depression after myocardial infarction, a significant portion of these data have provided more questions than answers. Although limited, the randomized prospective clinical trial data evaluating interventions for the management of depression after myocardial infarction in patients with ischemic heart disease continue to produce promising findings for progressive and improved management of these devastating diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20730574     DOI: 10.1007/s11897-010-0024-6

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  48 in total

1.  Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarction.

Authors:  N Frasure-Smith; F Lespérance; R H Prince; P Verrier; R A Garber; M Juneau; C Wolfson; M G Bourassa
Journal:  Lancet       Date:  1997-08-16       Impact factor: 79.321

2.  The safety of tricyclic antidepressants in cardiac patients. Risk-benefit reconsidered.

Authors:  A H Glassman; S P Roose; J T Bigger
Journal:  JAMA       Date:  1993-05-26       Impact factor: 56.272

3.  Cardiovascular effects of imipramine and bupropion in depressed patients with congestive heart failure.

Authors:  S P Roose; A H Glassman; E G Giardina; L L Johnson; B T Walsh; J T Bigger
Journal:  J Clin Psychopharmacol       Date:  1987-08       Impact factor: 3.153

4.  Pharmacoeconomic analysis of sertraline treatment of depression in patients with unstable angina or a recent myocardial infarction.

Authors:  Christopher M O'Connor; Alexander H Glassman; David J Harrison
Journal:  J Clin Psychiatry       Date:  2005-03       Impact factor: 4.384

5.  Even minimal symptoms of depression increase mortality risk after acute myocardial infarction.

Authors:  D E Bush; R C Ziegelstein; M Tayback; D Richter; S Stevens; H Zahalsky; J A Fauerbach
Journal:  Am J Cardiol       Date:  2001-08-15       Impact factor: 2.778

Review 6.  Treatment of depression in patients with congestive heart failure.

Authors:  Peter A Shapiro
Journal:  Heart Fail Rev       Date:  2007-10-23       Impact factor: 4.214

7.  Depression and increased myocardial ischemic activity in patients with ischemic heart disease.

Authors:  Wei Jiang; Michael A Babyak; Alan Rozanski; Andrew Sherwood; Christopher M O'Connor; Robert A Waugh; R Edward Coleman; Michael W Hanson; James J Morris; James A Blumenthal
Journal:  Am Heart J       Date:  2003-07       Impact factor: 4.749

8.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R Kleiger; J P Miller; L M Rolnitzky
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

Review 9.  Impacts of depression and emotional distress on cardiac disease.

Authors:  Wei Jiang
Journal:  Cleve Clin J Med       Date:  2008-03       Impact factor: 2.321

10.  Rationale, design and methodology of a double-blind, randomized, placebo-controlled study of escitalopram in prevention of Depression in Acute Coronary Syndrome (DECARD).

Authors:  Baiba Hedegaard Hansen; Jamal Abed Hanash; Alice Rasmussen; Jørgen Fischer Hansen; Morten Birket-Smith
Journal:  Trials       Date:  2009-04-07       Impact factor: 2.279

View more
  3 in total

1.  Functional disability and cognitive impairment after hospitalization for myocardial infarction and stroke.

Authors:  Deborah A Levine; Dimitry S Davydow; Catherine L Hough; Kenneth M Langa; Mary A M Rogers; Theodore J Iwashyna
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-11-11

2.  The R93C Variant of PCSK9 Reduces the Risk of Premature MI in a Chinese Han Population.

Authors:  Lincheng Yang; Tian Pu; Yan Zhang; Hua Yan; Haiyi Yu; Wei Gao
Journal:  Front Genet       Date:  2022-04-11       Impact factor: 4.772

3.  Comorbidity profiles and inpatient outcomes during hospitalization for heart failure: an analysis of the U.S. Nationwide inpatient sample.

Authors:  Christopher S Lee; Christopher V Chien; Julie T Bidwell; Jill M Gelow; Quin E Denfeld; Ruth Masterson Creber; Harleah G Buck; James O Mudd
Journal:  BMC Cardiovasc Disord       Date:  2014-06-05       Impact factor: 2.298

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.